Search for: "FOOD AND DRUG ADMINISTRATION" Results 841 - 860 of 23,778
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Feb 2024, 10:20 pm by Yosi Yahoudai
The federal government said consumers should consult the Food and Drug Administration’s table of recalled products for updated information about descriptions, sizes and best-by dates. [read post]
9 Feb 2024, 2:35 pm by News Desk
The Food and Drug Administration has been notified of additional recalls for products made with or containing recalled dairy products from Rizo Lopez Foods Inc. [read post]
9 Feb 2024, 12:03 pm by Tom Lamb
Its effects increase in a dose-proportional manner, and a steady state is achieved after four to five weeks of once-weekly administration. [read post]
9 Feb 2024, 11:08 am by Guest Author
The Food and Drug Administration (FDA) relies on broad judicial deference granted by Chevron, with the primary goal of utilizing scientific and clinical expertise to protect the health and safety of the public. [read post]
8 Feb 2024, 10:00 pm
The US Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health recently announced its intention to reclassify certain high-risk in vitro diagnostic devices (IVDs) as moderate risk, a potential first step as the agency prepares to oversee laboratory-developed tests (LDTs). [read post]
8 Feb 2024, 10:00 pm
In the FY 2022 HCFAC, DOJ and HHS not only highlighted a series of fraud and abuse enforcement wins, but also indicated increased activity by and with the US Food and Drug Administration (FDA) and the DOJ Consumer Protection Branch (CPB). [read post]
8 Feb 2024, 10:00 pm
The US Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health recently announced its intention to reclassify certain high-risk in vitro diagnostic devices (IVDs) as moderate risk, a potential first step as the agency prepares to oversee laboratory-developed tests (LDTs). [read post]
8 Feb 2024, 10:00 pm
The US Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health recently announced its intention to reclassify certain high-risk in vitro diagnostic devices (IVDs) as moderate risk, a potential first step as the agency prepares to oversee laboratory-developed tests (LDTs). [read post]
8 Feb 2024, 10:00 pm
The US Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health recently announced its intention to reclassify certain high-risk in vitro diagnostic devices (IVDs) as moderate risk, a potential first step as the agency prepares to oversee laboratory-developed tests (LDTs). [read post]
8 Feb 2024, 10:00 pm
The US Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health recently announced its intention to reclassify certain high-risk in vitro diagnostic devices (IVDs) as moderate risk, a potential first step as the agency prepares to oversee laboratory-developed tests (LDTs). [read post]
8 Feb 2024, 10:00 pm
In the FY 2022 HCFAC, DOJ and HHS not only highlighted a series of fraud and abuse enforcement wins, but also indicated increased activity by and with the US Food and Drug Administration (FDA) and the DOJ Consumer Protection Branch (CPB). [read post]
8 Feb 2024, 10:00 pm
In the FY 2022 HCFAC, DOJ and HHS not only highlighted a series of fraud and abuse enforcement wins, but also indicated increased activity by and with the US Food and Drug Administration (FDA) and the DOJ Consumer Protection Branch (CPB). [read post]
8 Feb 2024, 10:00 pm
In the FY 2022 HCFAC, DOJ and HHS not only highlighted a series of fraud and abuse enforcement wins, but also indicated increased activity by and with the US Food and Drug Administration (FDA) and the DOJ Consumer Protection Branch (CPB). [read post]
8 Feb 2024, 10:00 pm
In the FY 2022 HCFAC, DOJ and HHS not only highlighted a series of fraud and abuse enforcement wins, but also indicated increased activity by and with the US Food and Drug Administration (FDA) and the DOJ Consumer Protection Branch (CPB). [read post]
8 Feb 2024, 10:00 pm
The US Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health recently announced its intention to reclassify certain high-risk in vitro diagnostic devices (IVDs) as moderate risk, a potential first step as the agency prepares to oversee laboratory-developed tests (LDTs). [read post]
8 Feb 2024, 10:00 pm
In the FY 2022 HCFAC, DOJ and HHS not only highlighted a series of fraud and abuse enforcement wins, but also indicated increased activity by and with the US Food and Drug Administration (FDA) and the DOJ Consumer Protection Branch (CPB). [read post]
8 Feb 2024, 8:15 am by Jeffrey S. Glassman
Food and Drug Administration (FDA) has issued critical updates on the recall of specific Philips Respironics CPAP, BiPAP, and ventilator machines, highlighting the serious nature of the situation with 561 deaths associated with these devices since the recall began in 2021. [read post]
6 Feb 2024, 9:05 pm by Dan Flynn
” The bipartisan commenters continued to say: “Changes in FSIS animal raising claim requirements must also be considered in consultation with the Food and Drug Administration (FDA) since a policy shift could also impact FDA regulated products (e.g., dairy and shell eggs). [read post]
6 Feb 2024, 3:58 pm by Heather Boutet
Food and Drug Administration (FDA) receives more than 100,000 U.S. reports each year associated with a suspected medication error  An estimated 800,000 preventable medication‐related injuries occur every year in long‐term care facilities in the U.S. [read post]